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The Effect of Erythropoietin in Acute Pancreatitis:
An Experimental Study
Background: Although the pathogenesis of acute pancreatitis is not clearly known, the most frequently
mentioned factors are proinflammatory cytokines and nitric oxide (NO), which is stimulated by bacterial
endotoxins. The relationship of erythropoietin (EPO), which is an erythroid line growth hormone, with
proinflammatory cytokines and NO is also not clear. EPO has a well-known general tissue protective effect,
yet its role in an inflammatory presentation like that of acute pancreatitis has not been investigated and
documented. Therefore, the aim of this study was to investigate the role of EPO in acute pancreatitis.
Materials and Methods: 60 Wistar Albino rats were divided into 4 groups as follows: laparotomy (I),
pancreatitis (II), pancreatitis + simultaneous application of EPO (III) and finally pancreatitis + administration
of EPO after 3 hours (IV). The groups were further separated to subgroups by sacrificing the animals at 3, 6
and 24 hours. Pancreatitis was induced by injecting 4.5% sodium (Na)-taurocholate (0.1 ml / 100 g) into the
pancreatic canal. Leukocyte counts and serum amylase and C-reactive protein (CRP) levels were measured.
Histopathological changes of the pancreas were evaluated according to Spormann scores.
Results: EPO was shown to increase leukocyte counts in the early phase (P < 0.05) though the effect
diminished in time. It also had an increasing effect on amylase in the early hours (P < 0.005), but the
difference between the groups disappeared in the following hours. No effect was demonstrated on serum CRP.
Pancreatic tissue revealed moderate degree of pancreatitis in group III sacrificed at 6 hours and in group IV
evaluated at 6 and 24 hours. Despite the absence of a difference in the numerical analysis of Spormann scoring
(P > 0.05), moderate pancreatitis developed in the group receiving EPO.
Conclusions: The results we have obtained demonstrate that more controlled models (employing low rates
of sodium taurocholate or edematous pancreatitis) are necessary to better investigate the efficacy of EPO.
Key Words: Acute pancreatitis, experimental model, histopathology, erythropoietin

Eritropoetinin Akut Pankreatit Üzerine Etkisi: Bir Deneysel Çal›ﬂma
Amaç: Akut pankreatitin patogenezi net olarak ortaya konamamakla beraber en çok üzerinde durulan,
proinflamatuar sitokinler ve bakteriyel endotoksinlerin stimule etti¤i nitrik oksittir. Bir eritroid seri büyüme
hormonu olan eritropoetinin (EPO) ise proinflamatuar sitokinlerle ve NO ile iliﬂkisi net de¤ildir. EPO’ nun genel
doku protektif etkisi oldu¤u bilinmekle beraber akut pankreatit gibi inflamatuar bir tabloda nas›l etki
gösterdi¤i araﬂt›r›lmam›ﬂt›r ve bilinmemektedir. Bu çal›ﬂman›n amac› akut pankreatitte EPO’nun etkisini
araﬂt›rmakt›r.
Yöntem ve Gereç: 250-300 gr a¤›rl›¤›nda 60 adet Wistar Albino rat 4 gruba ayr›ld›. Bunlar, (I) Laparotomi,
(II) pankreatit, (III) pankreatit + eﬂzamanl› EPO uygulanan ve (IV) pankreatit + 3 saat sonra EPO uygulanan
gruplard›. Her grup ayr›ca 3., 6., 24. saatlerde sakrifikasyon için ayr›ld›. Pankreatik kanala % 4.5 Na
taurokolat (0.1 ml / 100 gr) injeksiyonu ile akut pankreatit oluﬂturuldu. Lökosit, amilaz, CRP seviyesi ve
pankreasta (Spormann skorlamas›na göre) histopatolojik de¤iﬂiklik araﬂt›r›ld›.
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Bulgular: Erken saatlerde EPO’nun lökosit de¤erlerini art›rd›¤› (P < 0.05) ancak zaman geçtikçe etkisinin
silikleﬂti¤i tespit edilmiﬂtir. Amilaz üzerine de erken saatte art›r›c› etki gösterdi¤i (P < 0.005), ilerleyen
saatlerde gruplar aras›nda fark kalmad›¤›n› göstermiﬂtir. Serum CRP’si üzerine herhangi bir etkisi ortaya
konulamam›ﬂt›r. Pankreas dokusunda, rakamsal olarak 6.saatte sakrifiye edilen III. grupta ve 6. ve 24.
saatlerde incelenen IV. gruplarda orta ﬂiddette pankreatite rastlanm›ﬂt›r. Sporman skorlamas›n›n rakamsal
analizinde anlaml› farkl›l›k olmamas›na (P > 0,05) karﬂ›n, ortaya ç›kan orta ﬂiddetteki pankreatit EPO verilen
gruplarda oluﬂmuﬂtur.
Sonuç: Lökosit ve amilaz de¤erlerinde erken saatlerdeki anlaml› farkl›l›k ilerleyen saatlerde belirsizleﬂmiﬂtir.
Histopatolojik olarak modelin yaratt›¤› ﬂiddetli tablo nedeniyle, daha kontrollü pankreatit tablosunda (düﬂük
oranl› Na taurokolat kullan›lan veya ödematöz pankreatit oluﬂturulan modellerde) EPO’nun etkinli¤i, ortaya
aç›k olarak konabilir. EPO’nun amilaz ve lökosit üzerine etkisi oldu¤u ön görülmekle birlikte, hafif pankreatit
tablosunda etki, daha net gözlenebilir.
Anahtar Sözcükler: Akut Pankreatit, deneysel model, histopatoloji, eritropoetin
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Introduction
The pancreas is an organ that secretes important
enzymes and bioactive amines required for the digestion
of carbohydrates, protein and lipids. Under normal
conditions, these strong enzymes do not cause any harm
to the pancreatic tissue itself. The secretion of such
enzymes in inactive forms and the presence of specific
storing systems in pancreatic acini and of locally and
systemically acting protease inhibitors in the pancreas
protect it against these enzymes.
Factors hindering such protective systems result in
acute pancreatitis by activating the enzymes and bioactive
substances that are in their inactive forms. Clinical and
experimental studies have not been able to clearly
delineate the etiopathogenesis of acute pancreatitis (1-5).
Each of these responsible factors affects acinar cells in
various ways resulting in the retention of potent
proteolytic enzymes and their premature activation (3,6).
These active enzymes damage acinar cells, which results
in rapid secretion of cytokines thereby activating the
complement system (7,8). The complement system
attracts inflammatory cells like neutrophils and results in
their accumulation; neutrophils, on the other hand, are
responsible for further secretion of cytokines, free
radicals and vasoactive amines like nitric oxide (NO) (9).
The inflammatory molecules that are secreted induce
pancreatic edema, local effects like necrosis and systemic
complications (5,6,10). Cytokines secreted in pancreatitis
stimulate apoptosis, which later results in cellular death
(3,11,12).
Erythropoietin (EPO) is a member of the cytokine
super family and a growth hormone for erythroid lineage.
Among its non-erythropoietic effects, it diminishes to a
significant degree the edema of inflamed and hypoxicischemic tissues and cellular apoptosis, controls
inflammation, and lowers tissue lipid peroxidation and
generation of malondialdehyde (MDA) (13,14). In clinical
conditions like sepsis, in which inflammation cannot be
controlled due to the increases in main cytokines like
tumor necrosis factor (TNF)-α and interleukin (IL)-β,
serum EPO levels have been shown to be suppressed.
However, it is not known how the levels of these
cytokines or the inflammation itself are affected by the
administration of EPO. It has been experimentally
demonstrated that NO, the effects of which on the
pancreas are controversial, is being suppressed in various
ways via administration of EPO (13-15).
216
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In this study we planned to investigate whether the
events in the early stages of acute pancreatitis were
influenced by EPO and if so, to show to what extent this
was a problem. To this end, during the peroperative stage
at which acute pancreatitis was triggered or three hours
thereafter, erythropoietin was administered. If EPO
demonstrated any effect, it was further investigated
whether the time of administration was influential.
Furthermore, in the presence of an EPO effect, we
attempted to histopathologically and biochemically
evaluate the changes in the severity of pancreatitis
according to different times of sacrifice.

Materials and Methods
60 Wistar Albino rats weighing between 250 – 300 g
were used for the experiment. All rats underwent
laparotomy under 50 mg/kg ketamine anesthesia
®
(Ketalar , Eczacıbaﬂı Warner-Lambert, ‹stanbul, Turkey).
For inducing acute pancreatitis, the pancreatic canal
was approached and 4.5% sodium (Na) taurocholate (0.1
ml / 100 g) (Sigma-Aldrich, Steinheim, Germany) was
infused according to retrograde ductal injection model
(16-18).
Study protocol (Table 1):
Group I: Sham group (n = 15);
Group II: Control group: acute pancreatitis was
induced with the injection of 4.5% Na taurocholate into
the pancreatic canal and EPO was not administered (n =
15);
Group III: Study group: acute pancreatitis was induced
with the injection of 4.5% Na taurocholate into the
pancreatic canal and EPO was simultaneously
®
administered at 400 IU/kg subcutaneously (Eprex 4000
IU/vial Cilag AG, Zug, Switzerland) (n = 15);
Group IV: Acute pancreatitis was induced with the
injection of 4.5% Na taurocholate into the pancreatic
canal and EPO was administered at 400 IU/kg
®
subcutaneously 3 hours later (Eprex 4000 IU/vial Cilag
AG, Zug, Switzerland) (n = 15).
After 12 hours of fasting, all rats received 50 mg/kg
intramuscular ketamine anesthesia. The abdomen was
shaved and cleansed with povidone-iodine solution
followed by laparotomy. Pancreas and pancreaticobiliary
canal were explored and main biliary duct was
approached and clipped at its last third portion before
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Acute
Pancreatitis

Sham group
Group I

Control
Group II

Pancreatitis +
EPO Simultaneus
Group III

Pancreatitis + EPO
after 3 hours
Group IV

Sacrification
Time
3rdrd...... I-3..............II-3................................III-3....................................IV-3.................
6th

.....I-6...............II-6................................III-6....................................IV-6.................

24th

...I-24.............II-24..............................III-24..................................IV-24..............

Table 1. Study groups.

joining to pancreatic canal. In this way, it was attempted
to eliminate any possible irritating effects of the biliary
salt to be administered. The orifice of the
pancreaticobiliary duct was passed with a 26 G catheter
through transduodenal route; upon visualization of the
catheter within the canal, 4.5% Na taurocholate (0.1 ml
/ 100 g) was manually infused into the pancreatic canal
under minimal pressure at a very slow rate. Following the
perfusion, the catheter was retrieved; the transduodenal
entry hole was sutured with 6/0 round needled prolene to
avoid any leakage. Abdominal cavities of all the rats were
closed with 3/0 interrupted silk sutures. Immediately
after the closure of the abdomen, Group III received SC
400 IU/kg EPO and Group IV received the same dose
after three hours.
The groups were further separated into subgroups to
rd
th
th
be sacrificed at the 3 , 6 , and 24 hours (n = 5). The
rats underwent relaparotomy under 50 mg/kg ketamine
rd
th
th
anesthesia at the planned (3 , 6 , 24 ) hours. 5 ml of
blood was obtained from the right ventricles of all rats
with heparin-flushed syringes and the rats were sacrificed
with cardiac approach. Blood samples were transferred
into 2-3 ml vacutainer tubes for biochemical analysis and
1-2 ml blood was transferred to tubes with EDTA for
complete blood count.
Measurement methods
The obtained blood samples were assayed for
leukocytes, amylase and C-reactive protein (CRP).
Leukocytes were measured (Cell-dyne, Abbott, Santa
Clara, USA) with laser reading method; amylase (Olympus

AU2700, Mishima, Japan) with enzymatic method; and
CRP with immunoturbidimetric technique with the same
analyzer.
Histological examination
The pancreatic tissue obtained after sacrifice was
separated into five regions to obtain an average of
histopathological findings and scoring. Samples were
obtained from the following regions (Figure 1):
1. inferior of stomach
2. around the second part of duodenum
3. around the opening of the common
pancreaticobiliary canal into the duodenum; head
and body of pancreas
4. around the fourth part of duodenum and superior
of proximal jejunum
5. he tail of the pancreas adjacent to spleen hilus
The tissue sections were stained with hematoxylineosin and were evaluated according to Spormann scores
(19,20) (Table 2).
Statistical analysis
For comparison between the groups, one way ANOVA
and Tukey post hoc tests were used. For the calculation
of p value between repetitive measurements, Student’s t
test was used.
Means of all the measurements were obtained and are
given in the Tables along with standard deviations. A p
value of < 0.05 was accepted as having statistical
significance.
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At 6 hours, leukocyte levels were lowest in group II
with pancreatitis (P < 0.05). In Group IV that had EPO
effect for 3 hours, leukocyte levels were higher than
those of group III (P < 0.001). Leukocyte levels of all
groups were similar at 24 hours (Table 3).
5

2

1

Table 3. Mean leukocyte levels (SD) of the groups.

3
3rd hour

6th hour

24th hour

I

2880.0 (460.4)

5588.0 (179.0)

2826.7 (176.0)

II

10270.0 (733.0)

8770.0 (264.0)

4052.0 (387.0)

III

11900.0 (215.0)

9878.0 (311.0)

4417.0 (852.0)

IV

10848.0 (174.5)

11970.0 (345.3)

4246.0 (265.5)

Groups
4

Figure 1. Histopathological samples were obtained from the pancreatic
regions.
(1. inferior of stomach, 2. around the second part of
duodenum, 3. around the opening of the common
pancreaticobiliary canal into the duodenum; head and body of
pancreas, 4. around the fourth part of duodenum and
superior proximal jejunum, 5. the tail of pancreas adjacent to
spleen hilus).

When different times of sacrifice were compared, it
was seen that the leukocyte levels that were highest at 3
hours decreased considerably thereafter (p: 0.005).
Serum amylase measurements

Table 2. Spormann scores (19,20).
Findings

Severity

Score

Edema

Mild
Moderate
Severe

1
2
3

‹nflammation

Mild
Moderate
Severe

1
2
3

Fat necrosis

<2
3-5
<5

3
5
7

Mild
Moderate
Severe

3
5
7

Among the groups analyzed at 3 hours, amylase levels
were highest in group III (P < 0.005). Mean amylase level
of group IV was close to this value (P > 0.05).
Although the parameters of all the groups were close
in value by 6 hours, group II levels were higher (P > 0.05).
Mean values at 24 hours were similar to mean values
at 6 hours (P > 0.05) (Table 4).
Table 4. Mean amylase levels (SD) of the groups.

Parenchymal necrosis

Hemorrhage

Mild
Moderate
Severe

3
5
7

Groups

3rd hour

6th hour

24th hour

I

454.8 (15.5)

676.6 (18.0)

288.4 (38.0)

II

2209.6 (288.0)

3922.2 (441.0)

3948.0 (347.6)

III

3019.2 (441.0)

3629.0 (597.0)

3820.0 (355.0)

IV

2368.0 (254.0)

3250.0 (314.0)

3494.0 (441.0)

Evaluation of different hours of sacrifice revealed that
amylase levels increased over time (P < 0.05).
Serum CRP levels

Results
Biochemical Evaluation
Leukocyte levels
Among the groups sacrificed at 3 hours, leukocyte
levels were highest in group III and this was more
significant than in other groups (P < 0.005).
218

No group other than the laparotomy group had
significantly different levels of mean CRP (P > 0.05)
(Table 5). At different hours of sacrifice in the same
groups, CRP showed insignificant decreases from the 3rd
to 6th hours and showed significant increases at 24 hours
(P ≤ 0.002).
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Table 5. Mean CRP levels (SD) of the groups.

Discussion

3rd hour

6th hour

24th hour

I

22.2 (2.7)

18.2 (1.5)

29.2 (1.6)

II

33.2 (2.0)

27.4 (1.7)

63.2 (6.0)

III

33.2 (3.6)

26.8 (3.6)

65.2 (7.0)

IV

33.2 (2.0)

27.4 (1.1)

64.8 (5.8)

Groups

Histopathological Examination
The tissues obtained from the pancreas were
separated as explained above and were evaluated
according to Spormann scores (19,20) (Table 6). The
highest score was 27, correlating with the most severe
form of pancreatitis. This score was divided by three and
further classification was as follows: Mild ≤11, moderate:
11-19, and severe pancreatitis: 19-27.
Table 6. Spormann score (SD) of the groups.
Groups

3rd hour

6th hour

24th hour

I

6.0 (0.3)

5.8 (0.3)

5.9 (0.4)

II

19.5 (1.2)

19.4 (0.9)

20.3 (0.7)

III

19.7 (0.4)

17.9 (1.0)

19.9 (0.7)

IV

19.4 (1.0)

16.2 (0.5)

17.9 (0.9)

The pancreatic tissue of the laparotomy group
corresponded to the mildest degree of pancreatitis among
all groups (P ≤ 0.002) (Table 7). In group III sacrificed at
6 hours and group IV sacrificed at 6 and 24 hours,
pancreatitis was moderate; other groups had severe
pancreatitis. However, none of the parameters in the
Spormann scoring criteria was different or significant.
Furthermore, groups administered EPO showed
similarities.
Table 7. Pancreatitis classification of all groups according to Spormann
scores.
3rd hour

6th hour

24th hour

Mild

Mild

Mild

II

Severe

Severe

Severe

III

Severe

Moderate

Severe

IV

Severe

Moderate

Moderate

Groups
I

August 2006

As animal models of retrograde injection/perfusion of
bile salts (Na taurocholate) into the pancreatic canal had
similar etiological factors with that of humans, while
resulting in similar local and remote effects and making it
possible to investigate different therapeutic modalities,
this was chosen as the model in our study (21). An
experimental model of acute pancreatitis has been
successfully created as shown by biochemical and
histopathological examinations.
While EPO increased leukocytosis in the early hours,
this effect disappeared in time resulting in a decrease in
leukocytes at 24 hours. EPO also caused an increase in
amylase levels in the early hours, yet this effect that
created a difference among the groups was short-lived,
and was not observed in the following hours. The severity
of the pancreatitis seen in this model might have masked
the influence of EPO on amylase levels.
CRP is a marker dictating the severity of acute
th
nd
pancreatitis, with a value between the 48 -72 hours
(22). In our study groups CRP levels remained unchanged
until 24 hours and started increasing thereafter, and this
finding is consistent with the information in the
literature. Interestingly, there was an insignificant
decrease between the 3rd to 6th hours. This slight
decrease in early hours might be similar to the changes in
IL-6 (9), since it is well known that CRP correlates with
increases in IL-6 (3,23), though CRP makes a later peak
in comparison (24). Thus, CRP has lower sensitivity and
specificity during the early stages of inflammation (4,6).
The increase in the levels of serum calcium or the
cytosolic calcium in the acinar cells is known to be one of
the initiating events for acute pancreatitis (25).
Increasing levels of cytosolic calcium result in the
activation of zymogen granules, which play an important
role in early stages of pancreatitis (26). Several research
studies have shown that for a rapid and limited period of
++
time, EPO increases the intracellular cytosolic [Ca ]
concentration, thus increasing cellular excitability
(13,14,27-29).
EPO is identified to have receptors in different tissues
(30,31). However, there is no data regarding the
presence of its receptors in the pancreas. In the event of
EPO receptors in the pancreas, we might anticipate an
increase in the severity of pancreatitis together with an
increase in the concentrations of cytosolic calcium.
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However, EPO did not aggravate pancreatitis in this
study.
Despite being insignificant, EPO resulted in an
increase in amylasemia in this study. The group
administered EPO and the pancreatitis group did not
differ regarding pancreatic edema.
In smooth muscle cell cultures, Kusano et al. (32)
demonstrated that EPO prevented the productions of NO
and cyclic guanosine monophosphate (cGMP) as
stimulated by IL-1β, thereby regulating cellular apoptosis.
Excessive production of NO as a result of the stimulation
of cytokines can be prevented with EPO administration;
therefore, hypotensive effects of NO can be reversed with
EPO (32).
High levels of cytokines in the body aggravate a
variety of disease states. Gene rally, the presence of
cytokines in the body or increases thereof (in conditions
like inflammation or sepsis) reduce the concentrations of
EPO (33,34). However, Krafte-Jacobs and Bock (35)
identified increases in EPO together with IL-6 in
circulations of children with sepsis or septic shock.
Activation of peritoneal macrophages is known to
have a role in acute pancreatitis. Rendering of peritoneal
macrophages passive by EPO will at least eliminate the
contribution of these cells to the severity of acute
pancreatitis. However, in this study neuronal ischemic
damage induced by the generation of NO was prevented
by EPO either by decreasing free radicals generated via
NO or by antagonizing their toxicities (15). In a brain
ischemia model in rats, EPO was administered

Turk J Med Sci

immediately after the injury; thereby excessive production
of NO, which induced ischemic injury, was suppressed,
levels of post-ischemic MDA, brain edema and neuronal
loss were all reduced and survival was lengthened (36).
We still do not know what type of an effect EPO
exerts in the tissue in case of acute pancreatitis. This
study demonstrated that EPO increased the levels of
leukocytes in the early hours but the difference
disappeared in time. It had an increasing effect on
amylase within the first 3 hours and caused insignificant
decreases at 6 and 24 hours. It is possible that in the
presence of edematous pancreatitis, the influence of EPO
on amylase can be more clearly demonstrated. No effect
could be demonstrated on serum CRP. The laparotomy
group had mild pancreatitis due to surgical trauma and
minimal manipulation. There was moderate degree of
pancreatitis at 6 hours in group III and at 6 and 24 hours
in group IV. In the numerical analysis of Spormann
scoring, there was no significant difference; however,
moderate pancreatitis was present in groups
administered EPO. Edema, inflammation, fat necrosis,
parenchymal necrosis and hemorrhage were the
parameters investigated by Spormann scoring and none
of them showed any difference. The severity of the
pancreatitis induced prevented satisfactory evaluation of
the mentioned parameters.
The results we have obtained demonstrate that more
controlled models (employing low rates of sodium
taurocholate or edematous pancreatitis) are necessary to
better investigate the efficacy of EPO.
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